Dr. Peder Holk Nielsen has been the Chief Executive Officer and President of Novozymes A/S since April 1, 2013. Mr. Nielsen served as an Executive Vice President of Enzyme Business at Novozymes A/S from 2007 to April 1, 2013. He served as the Head of Enzymes Business at Novozymes A/S. Mr. Nielsen served as an Executive Vice President of Sales & Marketing at Novozymes A/S. He served as Corporate Vice president for Enzyme Development & Industrial Biotechnology at Novo Nordisk. He serves as a Director of Hempel (China) Ltd., LEO Pharma A/S and Hempel A/S. He served as a Member of Advisory Board at Center for Biocatalysis and Bioprocessing. Mr. Nielsen holds an MS and PhD from Technical University of Denmark and has a B.Com from Copenhagen Business School.
Announcing New Members of Concordia’s Advisory Board
Concordia is pleased to announce the appointment of a distinguished group of global leaders to its Advisory Board. Representing a diverse range of sectors, geographies, and areas of expertise, these individuals bring
